Musci MD - Search Results

1

Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms.

Abbate I, Correale M, Gargano G, Tedone T, Izzi G, Catino A, Musci MD, Dragone D, Cramarossa A. Abbate I, et al. Among authors: musci md. Eur J Gynaecol Oncol. 1992;13(1 Suppl):92-6. Eur J Gynaecol Oncol. 1992. PMID: 1511722

2

Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasms.

Correale M, Abbate I, Catino A, Tedone T, Musci MD, Dragone D, Gargano G, Izzi G, Cramarossa A. Correale M, et al. Among authors: musci md. Eur J Gynaecol Oncol. 1992;13(1 Suppl):82-4. Eur J Gynaecol Oncol. 1992. PMID: 1511720

3

Modification of soluble immunological parameters during treatment with interleukin-2.

Abbate I, Correale M, Musci MD, Guida M, Dragone CD, De Santis M, De Lena M. Abbate I, et al. Among authors: musci md. Int J Biol Markers. 1993 Oct-Dec;8(4):227-32. doi: 10.1177/172460089300800405. Int J Biol Markers. 1993. PMID: 8138662

4

Evaluation of phagocytic-activity in neoplastic patients treated with subcutaneous recombinant IL-2.

Abbate I, Guida M, Musci M, Casamassima A, Latorre A, Addabbo L, Dragone C, Cattedra M, Correale M, Delena M. Abbate I, et al. Int J Oncol. 1993 Oct;3(4):603-6. doi: 10.3892/ijo.3.4.603. Int J Oncol. 1993. PMID: 21573406

5

[The determination of sialic acid in cancer patients].

Correale M, Abbate I, Gargano G, Catino A, Musci MD, Dragone CD, De Lena M. Correale M, et al. Among authors: musci md. Minerva Med. 1992 Jul-Aug;83(7-8):427-31. Minerva Med. 1992. PMID: 1522966 Italian.

6

Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29.

Correale M, Abbate I, Gargano G, Catino A, Dragone CD, Musci MD, Serio G, Paradiso A, De Lena M. Correale M, et al. Among authors: musci md. Int J Biol Markers. 1992 Jan-Mar;7(1):43-6. doi: 10.1177/172460089200700106. Int J Biol Markers. 1992. PMID: 1583347

7

pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer.

Correale M, Abbate I, Paradiso A, Schittulli F, Dragone CD, Tedone T, Gargano G, Catino AM, Musci MD, De Lena M. Correale M, et al. Among authors: musci md. Cell Biophys. 1993 Jan-Jun;22(1-3):101-10. doi: 10.1007/BF03033869. Cell Biophys. 1993. PMID: 7889536

8

Serum and cytosolic levels of CA549 in breast cancer patients.

Correale M, Abbate I, Dragone CD, Tedone T, Gargano G, Catino A, Paradiso A, Addabbo L, Musci MD, De Lena M. Correale M, et al. Among authors: musci md. Clin Exp Obstet Gynecol. 1993;20(4):264-7. Clin Exp Obstet Gynecol. 1993. PMID: 8281711

9

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications.

Guida M, Abbate I, Casamassima A, Musci MD, Latorre A, Lorusso V, Correale M, De Lena M. Guida M, et al. Among authors: musci md. Cancer Biother. 1995 Fall;10(3):195-203. doi: 10.1089/cbr.1995.10.195. Cancer Biother. 1995. PMID: 8547958 Clinical Trial.

10

Effects of subcutaneous recombinant IL-2 on humoral immunity in advanced cancer-patients.

Casamassima A, Guida M, Latorre A, Abbate I, Triantafillou V, Musci M, Delena M. Casamassima A, et al. Int J Oncol. 1993 Aug;3(2):171-6. doi: 10.3892/ijo.3.2.171. Int J Oncol. 1993. PMID: 21573344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters